Login
Hexo NYSE: HEXO
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market.
| Name | Hexo |
| Ticker | HEXO |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
|
Price
52W Low/High |
6.91
1.75 / 10.28 |
| Momentum | Weak Up |
| Market cap | 444 M |
| 1Y Total Return |
236.58%
Strong |
| 1Y Volatility |
114.13%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market.
Details
| Ticker | HEXO |
| Name | Hexo |
| ISIN | CA4283043079 |
| CUSIP | 428304109 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Specialties |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 5/6/21
| Close Price | 6.91 |
| 52W Low/High | 1.75 / 10.28 |
| Market cap | 444 M |
| 1Y Total Return |
236.58%
Strong |
| 1Y Volatility |
114.13%
High Risk |
| Beta | -0.23 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -676.5% |
| Cash from Op. / Cur. Liabilities | -1.15 |
| Diluted Earnings / Share | -5.28 |
| ROE | - |
| ROIC | -90.1% |
| Price / Revenue | 8.9 |
| Price / Book | 1.3 |
| Price / CF | -7.6 |
| Current Ratio | 3.7 |
| Cur.Liabilities / Tot.Liabilities | 0.6 |
| Financial Leverage | 0.21 |
| in Mils USD |
rolling-year up to June
|
|||
|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | |
| Revenue |
60
|
36
|
4
|
|
| Gross Profit |
-
|
19
|
5
|
|
| R&D |
3
|
2
|
0
|
|
| EBITDA |
-405
|
-67
|
-15
|
|
| Operating Income |
-356
|
-66
|
-14
|
|
| Net Income exc. Extra |
-
|
-
|
-
|
|
| per Share | ||||
| Diluted avg Shares |
77
|
53
|
34
|
|
| EPS exc. Extra |
-5.28
|
-1.01
|
-0.52
|
|
| Dividend |
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | |
| Total Assets |
517
|
671
|
254
|
|
| Cash, Eq & Invt ShortTerm |
137
|
117
|
193
|
|
| Total Current Assets |
228
|
238
|
210
|
|
| Total Non-Current Assets |
289
|
432
|
44
|
|
| Intangibles |
12
|
183
|
3
|
|
| Total Liabilities |
102
|
69
|
9
|
|
| Total Current Liabilities |
62
|
63
|
9
|
|
| Long Term Debt |
40
|
5
|
0
|
|
| Shareholder equity |
413
|
601
|
245
|
|
| Cash Flow | 2020 | 2019 | 2018 | |
| Cash from Operations |
-71
|
-95
|
-17
|
|
| Depreciation |
0
|
0
|
1
|
|
| Cash from Investing |
-62
|
-6
|
-152
|
|
| Capex |
73
|
105
|
35
|
|
| Cash from Financing |
185
|
112
|
215
|
|
| Stock Issued |
150
|
90
|
114
|
|
| Debt (LT) Issued |
43
|
25
|
52
|
|
| Free Cash Flow |
-411
|
-55
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | |
| Net Profit Margin |
-
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
|
| Current Ratio |
3.7
|
3.8
|
22.8
|
|
| Financial Leverage D/E |
0.21
|
0.08
|
0.00
|
|
| Return on Capital Avg |
-90.1%
|
-4.1%
|
-19.5%
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available